Distalmotion, a robotic surgery company, has received FDA 510(k) clearance for the use of its Dexter Robotic Surgery System in adult cholecystectomy (gallbladder removal).
This milestone represents the second approved indication in the US, following De Novo clearance for inguinal hernia repair in Q4 2024.
Greg Roche, CEO of Distalmotion, says: “Cholecystectomy is a key procedure in general surgery, with approximately one million cases performed annually – of which 60 percent are performed in outpatient settings. [Read more…] about Distalmotion gains FDA clearance for robotic surgery system